Emmanuella-Faith Amoako, Paediatric Oncologist at Cape Coast Teaching Hospital and Director of Clinical Affairs at Yemaachi Biotechnology, shared a post on LinkedIn:
“Excited to share that I will be presenting not one, but two posters at ASCO 2026!
- Determinants of triple-negative breast cancer among African patients: Early results from The African Cancer Atlas
- Early lessons from the implementation of a pan-African clinico-genomic cancer platform: The African Cancer Atlas
These abstracts reflect the incredible work being done at Yemaachi Biotech, across African institutions and partnerships to advance equitable cancer genomics research, improve representation in precision oncology, and build sustainable clinico-genomic infrastructure on the continent.
Proud of the teams, collaborators, patients, and communities making this work possible. Looking forward to the conversations, learning, and collaborations at ASCO2026.
See you there!!”
Other articles about ASCO 2026 on OncoDaily.
